Lutathera CA 370 MBq/ml, Infusionslösung

7680665800028 CH-66580 Infusionslösung
Lutathera CA 370 MBq/ml, Infusionslösung
Lutathera CA 370 MBq/ml, Infusionslösung
Lutathera CA 370 MBq/ml, Infusionslösung
1 / 3
google

Article details

Package size
20.5 - 25
Selling units
20
Measure
ml
Galenic form
Infusionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
27/01/2026
Summary of Product Characteristics
Français
27/01/2026
Summary of Product Characteristics
Italien
27/01/2026

Detailed composition

Substance Quantity Type Category
lutetium(177-Lu(CA)) oxodotreotidum
370.0 MBQ Substance Wirkstoff (Principe actif)
acidum aceticum
- Substance HNIDK
natrii acetas
- Substance HNIDK
acidum penteticum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
acidum gentisicum
- Substance Konservierungsstoff (Conservateur)
E 300
- Substance ANTON
aqua ad iniectabile
- Substance HNIDK
natrium
3.24 MG Substance HBESI

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
66580
Drug name
Lutathera CA, Infusionslösung
Galenic form
LSPA
ATC Code
V10XX04
Authorization status
Z
Dispensing category
A
First authorization
25/06/2019
Authorization expiration date
31/12/9999
IT Number
17.02.
Domain
Human medicine
Field of application
gastroenteropankreatische neuroendokrine Tumore (GEP‑NET)

Package details

Description (FR)
LUTATHERA CA sol perf 370 MBq/ml flac
Description (DE)
LUTATHERA CA Inf Lös 370 MBq/ml Durchstf
Market launch
25/06/2019
Narcotic (BTM)
No

Other package sizes (1)

LUTATHERA sol perf 370 MBq/ml (#) fl
None None
GTIN: 7680665800011
Not in V1
Buy us a coffee Explore the data